0000880771-17-000128.txt : 20170816
0000880771-17-000128.hdr.sgml : 20170816
20170816200509
ACCESSION NUMBER: 0000880771-17-000128
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170815
FILED AS OF DATE: 20170816
DATE AS OF CHANGE: 20170816
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Xie Lan
CENTRAL INDEX KEY: 0001555794
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19825
FILM NUMBER: 171037508
MAIL ADDRESS:
STREET 1: 29F SHANGHAI TIMES SQUARE
STREET 2: NO. 93 HUAI HAI ZHONG ROAD
CITY: SHANGHAI
STATE: F4
ZIP: 200021
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SCICLONE PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000880771
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943116852
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 950 TOWER LANE
STREET 2: SUITE 900
CITY: FOSTER CITY
STATE: CA
ZIP: 94404-2125
BUSINESS PHONE: 650-358-3456
MAIL ADDRESS:
STREET 1: 950 TOWER LANE
STREET 2: SUITE 900
CITY: FOSTER CITY
STATE: CA
ZIP: 94404-2125
4
1
certent-form4.xml
PRIMARY DOCUMENT
X0306
4
2017-08-15
0000880771
SCICLONE PHARMACEUTICALS INC
SCLN
0001555794
Xie Lan
950 TOWER LANE, SUITE 900
FOSTER CITY
CA
94404
0
1
0
0
VP Finance, China CFO
Common Stock
2017-08-15
4
M
0
10000
0
A
10000
D
Common Stock
2017-08-16
4
S
0
10000
11.00
D
0
D
Restricted Stock Unit
2017-08-15
4
M
0
10000
0
D
Common Stock
10000
8000
D
Granted under the Issuer's 2015 Equity Incentive Plan.
Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
Each RSU will vest and be settled on August 15, 2017, subject to the reporting person's continued employment, but will terminate upon the occurrence of a change in control on or before March 31, 2017.
/s/ Friedhelm Blobel, Attorney-in-Fact For: Lan Xie
2017-08-16